Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Cancer Immunology, Immunotherapy : CII|November 30, 2006
In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccinesReshma Singh, Yvonne PatersonExpert Review of Vaccines|September 23, 2006
Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapyReshma Singh, Yvonne PatersonCancer Research|March 3, 2007
Immunoediting sculpts tumor epitopes during immunotherapyReshma Singh, Yvonne PatersonCancer Research|August 4, 2006
Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancerReshma Singh, Yvonne PatersonJournal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouseReshma Singh, Mary E Dominiecki, Elizabeth M Jaffee, et al.Expert Review of Vaccines|May 11, 2013
Live-attenuated Listeria-based immunotherapyJohn Rothman, Yvonne PatersonVaccine|February 1, 2003
Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hostsChristian Peters, Yvonne PatersonImmunological Investigations|August 19, 2006
Effects of the tumor microenvironment on the efficacy of tumor immunotherapyPaul Neeson, Yvonne PatersonCancer Biology & Therapy|February 9, 2010
Harnessing Listeria monocytogenes to target tumorsClaudia Gravekamp, Yvonne PatersonPageof 8